Skip to main content
Advertisement

Main menu

  • Home
  • Content
    • Current Issue
    • Accepted Manuscripts
    • Article Preview
    • Past Issue Archive
    • AJNR Case Collection
    • Case of the Week Archive
    • Classic Case Archive
    • Case of the Month Archive
  • Special Collections
    • Spinal CSF Leak Articles (Jan 2020-June 2024)
    • 2024 AJNR Journal Awards
    • Most Impactful AJNR Articles
  • Multimedia
    • AJNR Podcast
    • AJNR Scantastics
    • Video Articles
  • For Authors
    • Submit a Manuscript
    • Author Policies
    • Fast publishing of Accepted Manuscripts
    • Graphical Abstract Preparation
    • Manuscript Submission Guidelines
    • Imaging Protocol Submission
    • Submit a Case for the Case Collection
  • About Us
    • About AJNR
    • Editorial Board
  • More
    • Become a Reviewer/Academy of Reviewers
    • Subscribers
    • Permissions
    • Alerts
    • Feedback
    • Advertisers
    • ASNR Home
  • Other Publications
    • ajnr

User menu

  • Alerts
  • Log in
  • Log out

Search

  • Advanced search
American Journal of Neuroradiology
American Journal of Neuroradiology

American Journal of Neuroradiology

ASHNR American Society of Functional Neuroradiology ASHNR American Society of Pediatric Neuroradiology ASSR
  • Alerts
  • Log in
  • Log out

Advanced Search

  • Home
  • Content
    • Current Issue
    • Accepted Manuscripts
    • Article Preview
    • Past Issue Archive
    • AJNR Case Collection
    • Case of the Week Archive
    • Classic Case Archive
    • Case of the Month Archive
  • Special Collections
    • Spinal CSF Leak Articles (Jan 2020-June 2024)
    • 2024 AJNR Journal Awards
    • Most Impactful AJNR Articles
  • Multimedia
    • AJNR Podcast
    • AJNR Scantastics
    • Video Articles
  • For Authors
    • Submit a Manuscript
    • Author Policies
    • Fast publishing of Accepted Manuscripts
    • Graphical Abstract Preparation
    • Manuscript Submission Guidelines
    • Imaging Protocol Submission
    • Submit a Case for the Case Collection
  • About Us
    • About AJNR
    • Editorial Board
  • More
    • Become a Reviewer/Academy of Reviewers
    • Subscribers
    • Permissions
    • Alerts
    • Feedback
    • Advertisers
    • ASNR Home
  • Follow AJNR on Twitter
  • Visit AJNR on Facebook
  • Follow AJNR on Instagram
  • Join AJNR on LinkedIn
  • RSS Feeds

Welcome to the new AJNR, Updated Hall of Fame, and more. Read the full announcements.


AJNR is seeking candidates for the position of Associate Section Editor, AJNR Case Collection. Read the full announcement.

 

Research ArticlePharmacology Vignette

Bevacizumab (Avastin)

S.K. Mukherji
American Journal of Neuroradiology February 2010, 31 (2) 235-236; DOI: https://doi.org/10.3174/ajnr.A1987
S.K. Mukherji
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • Responses
  • References
  • PDF
Loading

Article Information

vol. 31 no. 2 235-236
DOI 
https://doi.org/10.3174/ajnr.A1987
PubMed 
20037132

Published By 
American Journal of Neuroradiology
Print ISSN 
0195-6108
Online ISSN 
1936-959X
History 
  • Received November 5, 2006
  • Accepted after revision November 6, 2006
  • Published online February 11, 2010.

Copyright & Usage 
Copyright © American Society of Neuroradiology

Author Information

  1. S.K. Mukherjia
  1. aFrom the Departments of Radiology, Otolaryngology Head Neck Surgery, Radiation Oncology, and Periodontics and Oral Medicine, University of Michigan Health System, Ann Arbor, Michigan.
  1. Please address correspondence to Suresh K. Mukherji, MD, Department of Radiology, B2 A209–5030, 1500 E Medical Center Dr, Ann Arbor, MI 48109-5030; e-mail: mukherji{at}umich.edu
View Full Text

Altmetrics

Cited By...

  • 80 Citations
  • 87 Citations
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • Glioblastoma and chemoresistance to alkylating agents: Involvement of apoptosis, autophagy, and unfolded protein response
    Sabine Hombach-Klonisch, Maryam Mehrpour, Shahla Shojaei, Craig Harlos, Marshall Pitz, Ahmed Hamai, Krzysztof Siemianowicz, Wirginia Likus, Emilia Wiechec, Brian D. Toyota, Reyhane Hoshyar, Amir Seyfoori, Zahra Sepehri, Sudharsana R. Ande, Forough Khadem, Mohsen Akbari, Adrienne M. Gorman, Afshin Samali, Thomas Klonisch, Saeid Ghavami
    Pharmacology & Therapeutics 2018 184
  • Combination therapy with immune checkpoint inhibitors (ICIs); a new frontier
    Somayeh Vafaei, Angelina O. Zekiy, Ramadhan Ado Khanamir, Burhan Abdullah Zaman, Arman Ghayourvahdat, Hannaneh Azimizonuzi, Majid Zamani
    Cancer Cell International 2022 22 1
  • Tumor Volume Estimation and Quasi-Continuous Administration for Most Effective Bevacizumab Therapy
    Johanna Sápi, Levente Kovács, Dániel András Drexler, Pál Kocsis, Dávid Gajári, Zoltán Sápi, Francesco Bertolini
    PLOS ONE 2015 10 11
  • The bone marrow microenvironment – Home of the leukemic blasts
    Manar S Shafat, Bruno Gnaneswaran, Kristian M Bowles, Stuart A Rushworth
    Blood Reviews 2017 31 5
  • Cancer combination therapies by angiogenesis inhibitors; a comprehensive review
    Mohammad Javed Ansari, Dmitry Bokov, Alexander Markov, Abduladheem Turki Jalil, Mohammed Nader Shalaby, Wanich Suksatan, Supat Chupradit, Hasan S. AL-Ghamdi, Navid Shomali, Amir Zamani, Ali Mohammadi, Mehdi Dadashpour
    Cell Communication and Signaling 2022 20 1
  • Structural Basis for Vascular Endothelial Growth Factor Receptor Activation and Implications for Disease Therapy
    Faheem Shaik, Gary Cuthbert, Shervanthi Homer-Vanniasinkam, Stephen Muench, Sreenivasan Ponnambalam, Michael Harrison
    Biomolecules 2020 10 12
  • A highly hemocompatible erythrocyte membrane-coated ultrasmall selenium nanosystem for simultaneous cancer radiosensitization and precise antiangiogenesis
    Ting Liu, Changzheng Shi, Linqi Duan, Zehang Zhang, Liangping Luo, Shreya Goel, Weibo Cai, Tianfeng Chen
    Journal of Materials Chemistry B 2018 6 29
  • Antibodies in oncology
    Vinochani Pillay, Hui K. Gan, Andrew M. Scott
    New Biotechnology 2011 28 5
  • Theranostic applications of selenium nanomedicines against lung cancer
    Shaowei Liu, Weifeng Wei, Jinlin Wang, Tianfeng Chen
    Journal of Nanobiotechnology 2023 21 1
  • Multifunctional Nanocarriers for Simultaneous Encapsulation of Hydrophobic and Hydrophilic Drugs in Cancer Treatment
    Chia-Wei Su, Chih-Sheng Chiang, Wei-Ming Li, Shang-Hsiu Hu, San-Yuan Chen
    Nanomedicine 2014 9 10
  • Hydrophobic ion pairing as a strategy to improve drug encapsulation into lipid nanocarriers for the cancer treatment
    Mariana Silva Oliveira, Gisele Castro Assis Goulart, Lucas Antônio Miranda Ferreira, Guilherme Carneiro
    Expert Opinion on Drug Delivery 2017 14 8
  • Temporal aspects of the action of ASA404 (vadimezan; DMXAA)
    Bruce C Baguley, Dietmar W Siemann
    Expert Opinion on Investigational Drugs 2010 19 11
  • Change in Pattern of Relapse After Antiangiogenic Therapy in High-Grade Glioma
    Ashwatha Narayana, Saroj D. Kunnakkat, Praveen Medabalmi, John Golfinos, Erik Parker, Edmond Knopp, David Zagzag, Patricia Eagan, Deborah Gruber, Michael L. Gruber
    International Journal of Radiation Oncology*Biology*Physics 2012 82 1
  • A Novel Bispecific Antibody Targeting PD-L1 and VEGF With Combined Anti-Tumor Activities
    Xiaopei Cui, Huifeng Jia, Hong Xin, Lei Zhang, Shi Chen, Simin Xia, Xue Li, Wei Xu, Xiaofang Chen, Yujie Feng, Xiaoyue Wei, Haijia Yu, Yanting Wang, Yifan Zhan, Xiangyang Zhu, Xuemei Zhang
    Frontiers in Immunology 2021 12
  • A retrospective analysis of low dose, intranasal injected bevacizumab (Avastin) in hereditary haemorrhagic telangiectasia
    C. Rohrmeier, H. G. Sachs, T. S. Kuehnel
    European Archives of Oto-Rhino-Laryngology 2012 269 2
  • Characteristics of Oral Mucosal Events Related to Bevacizumab Treatment
    Igor T. Gavrilovic, Yevgeniy Balagula, Alyx C. Rosen, Vijay Ramaswamy, Maura N. Dickler, Ira J. Dunkel, Mario E. Lacouture
    The Oncologist 2012 17 2
  • Metabolic Response of Glioblastoma to Superselective Intra-Arterial Cerebral Infusion of Bevacizumab: A Proton MR Spectroscopic Imaging Study
    J.Y. Jeon, I. Kovanlikaya, J.A. Boockvar, X. Mao, B. Shin, J. K. Burkhardt, K. Kesavabhotla, P. Christos, H. Riina, D.C. Shungu, A.J. Tsiouris
    American Journal of Neuroradiology 2012 33 11
  • Recent advances in antibody‐based immunotherapy strategies for COVID‐19
    Abdolreza Esmaeilzadeh, Samaneh Rostami, Pegah M. Yeganeh, Safa Tahmasebi, Majid Ahmadi
    Journal of Cellular Biochemistry 2021 122 10
  • Prevention of arthrofibrosis by monoclonal antibody against vascular endothelial growth factor: A novel use of bevacizumab in rabbits
    M.J. Emami, F.M. Jaberi, N. Azarpira, A.R. Vosoughi, N. Tanideh
    Orthopaedics & Traumatology: Surgery & Research 2012 98 7
  • VEGF targeted therapy in acute myeloid leukemia
    Antonio Rodriguez-Ariza, Chary Lopez-Pedrera, Enrique Aranda, Nuria Barbarroja
    Critical Reviews in Oncology/Hematology 2011 80 2
  • Design and synthesis of novel furan, furo[2,3-d]pyrimidine and furo[3,2-e][1,2,4]triazolo[1,5-c]pyrimidine derivatives as potential VEGFR-2 inhibitors
    Menna M.A. Abd El-Mageed, Amal A.M. Eissa, Awatef El-Said Farag, Essam Eldin A. Osman
    Bioorganic Chemistry 2021 116
  • Combination use of paclitaxel and avastin enhances treatment effect for the NSCLC patients with malignant pleural effusion
    Nan Qi, Fang Li, Xiaosong Li, Huanrong Kang, Hui Zhao, Nan Du
    Medicine 2016 95 47
  • Posterior reversible encephalopathy syndrome after bevacizumab therapy in a normotensive patient
    Ola Abbas, Ali Shamseddin, Sally Temraz, Ali Haydar
    BMJ Case Reports 2013 2013
  • Communicable Diseases of the Developing World
    P. K. Shukla, Pratiksha Singh, Ravindra Kumar Yadav, Smriti Pandey, Shome S. Bhunia
    2016 29
  • A New Bevacizumab Carrier for Intravitreal Administration: Focus on Stability
    Daniela Chirio, Elena Peira, Simona Sapino, Giulia Chindamo, Simonetta Oliaro-Bosso, Salvatore Adinolfi, Chiara Dianzani, Francesca Baratta, Marina Gallarate
    Pharmaceutics 2021 13 4
  • Radioimmunotherapy with 131I-Bevacizumab as a Specific Molecule for Cells with Overexpression of the Vascular Endothelial Growth Factor
    Saeb Ahmad Ashrafi, Seyed Jalal Hosseinimehr, Kambiz Varmira, Seyed Mohammad Abedi
    Cancer Biotherapy and Radiopharmaceuticals 2012 27 7
  • Vascular Toxicity Associated With Chemotherapy and Molecular Targeted Therapy: What Should a Radiologist Know?
    Saurabh Rohatgi, Jyothi P. Jagannathan, Michael H. Rosenthal, Kyung Won Kim, Nikhil H. Ramaiya, Katherine M. Krajewski
    American Journal of Roentgenology 2014 203 6
  • Commonalities Between COVID-19 and Radiation Injury
    Carmen I. Rios, David R. Cassatt, Brynn A. Hollingsworth, Merriline M. Satyamitra, Yeabsera S. Tadesse, Lanyn P. Taliaferro, Thomas A. Winters, Andrea L. DiCarlo
    Radiation Research 2020 195 1
  • Dynamic Susceptibility Contrast-Enhanced MR Perfusion Imaging in Assessing Recurrent Glioblastoma Response to Superselective Intra-Arterial Bevacizumab Therapy
    R. Singh, K. Kesavabhotla, S.A. Kishore, Z. Zhou, A.J. Tsiouris, C.G. Filippi, J.A. Boockvar, I. Kovanlikaya
    American Journal of Neuroradiology 2016 37 10
  • Exploring the Spectrum of VEGF Inhibitors’ Toxicities from Systemic to Intra-Vitreal Usage in Medical Practice
    Mariachiara Santorsola, Maurizio Capuozzo, Guglielmo Nasti, Francesco Sabbatino, Annabella Di Mauro, Giordana Di Mauro, Gianluca Vanni, Piera Maiolino, Marco Correra, Vincenza Granata, Oreste Gualillo, Massimiliano Berretta, Alessandro Ottaiano
    Cancers 2024 16 2
  • Pharmacogenetics for severe adverse drug reactions induced by molecular‐targeted therapy
    Chihiro Udagawa, Hitoshi Zembutsu
    Cancer Science 2020 111 10
  • Cerebral blood volume and apparent diffusion coefficient – Valuable predictors of non-response to bevacizumab treatment in patients with recurrent glioblastoma
    Lucie Petrova, Panagiotis Korfiatis, Ondra Petr, Daniel H. LaChance, Ian Parney, Jan C. Buckner, Bradley J. Erickson
    Journal of the Neurological Sciences 2019 405
  • Design and synthesis of some new 6-bromo-2-(pyridin-3-yl)-4-substituted quinazolines as multi tyrosine kinase inhibitors
    Ahmed K.B.A.W. Farouk, Heba Abdelrasheed Allam, Essam Rashwan, Riham F. George, Safinaz E-S. Abbas
    Bioorganic Chemistry 2022 128
  • Emerging applications of anti-angiogenic nanomaterials in oncotherapy
    Bicai Tang, Wenjuan Ma, Yunfeng Lin
    Journal of Controlled Release 2023 364
  • In-vitro Evaluation of Isatin Derivatives as Potent Anti-Breast Cancer Agents against MCF-7, MDA MB 231, MDA-MB 435 and MDA-MB 468 Breast Cancers Cell Lines: A Review
    Garima Chauhan, Dharam Pal Pathak, Faraat Ali, Pragya Dubey, Shaik Khasimbi
    Anti-Cancer Agents in Medicinal Chemistry 2022 22 10
  • Leakage decrease detected by dynamic susceptibility-weighted contrast-enhanced perfusion MRI predicts survival in recurrent glioblastoma treated with bevacizumab
    A. Hilario, J. M. Sepulveda, A. Hernandez-Lain, E. Salvador, L. Koren, R. Manneh, Y. Ruano, A. Perez-Nuñez, A. Lagares, A. Ramos
    Clinical and Translational Oncology 2017 19 1
  • Bevacizumab: A new take on therapy of muscle phase of Trichinella spiralis infection
    Dina Abou Rayia, Ahmad Othman, Samar Harras, Duaa Helal, Lamees Dawood, Shaimaa Soliman
    Acta Tropica 2022 230
  • Resveratrol: Its Path from Isolation to Therapeutic Action in Eye Diseases
    Roxana Pop, Adela Daescu, Dumitrita Rugina, Adela Pintea
    Antioxidants 2022 11 12
  • Translational Bioinformatics in Healthcare and Medicine
    Anam Beg, Rafat Parveen
    2021
  • An exploration of counterfeit medicine surveillance strategies guided by geospatial analysis: lessons learned from counterfeit Avastin detection in the US drug supply chain
    Raphael E Cuomo, Tim K Mackey
    BMJ Open 2014 4 12
  • Repositioning Bevacizumab: A Promising Therapeutic Strategy for Cartilage Regeneration
    Soojung Lee, Judee Grace E. Nemeño, Jeong Ik Lee
    Tissue Engineering Part B: Reviews 2016 22 5
  • Unexpectedly Durable Palliation of Metastatic Olfactory Neuroblastoma Using Anti-Angiogenic Therapy with Bevacizumab
    Erin M. Dunbar, Phyllis K. Pumphrey, Sharat Bidari
    Rare Tumors 2012 4 2
  • Current therapeutic options for glioblastoma and future perspectives
    Elisa Aquilanti, Patrick Y. Wen
    Expert Opinion on Pharmacotherapy 2022 23 14
  • Engineered Bifunctional Proteins for Targeted Cancer Therapy: Prospects and Challenges
    Yue Du, Jian Xu
    Advanced Materials 2021 33 48
  • Re-188 Enhances the Inhibitory Effect of Bevacizumab in Non-Small-Cell Lung Cancer
    Jie Xiao, Xiaobo Xu, Xiao Li, Yanli Li, Guobing Liu, Hui Tan, Hua Shen, Hongcheng Shi, Dengfeng Cheng
    Molecules 2016 21 10
  • Imaging acute effects of bevacizumab on tumor vascular kinetics in a preclinical orthotopic model of U251 glioma
    Tavarekere N. Nagaraja, Rasha Elmghirbi, Stephen L. Brown, Julian A. Rey, Lonni Schultz, Abir Mukherjee, Glauber Cabral, Swayamprava Panda, Ian Y. Lee, Malisa Sarntinoranont, Kelly A. Keenan, Robert A. Knight, James R. Ewing
    NMR in Biomedicine 2021 34 7
  • A Critical Review of Biological Properties, Delivery Systems and Analytical/Bioanalytical Methods for Determination of Bevacizumab
    Leonardo Delello Di Filippo, Karen Cristina dos Santos, Gilmar Hanck-Silva, Felipe Tita de Lima, Maria Palmira Daflon Gremião, Marlus Chorilli
    Critical Reviews in Analytical Chemistry 2020
  • Genetic inhibition of vascular endothelial growth factor receptor-1 significantly inhibits the migration and proliferation of leukemia cells and increases their sensitivity to chemotherapy
    BING XIU, WENJUN ZHANG, BINBIN HUANG, JINGDE CHEN, HUINA LU, JIANFEI FU, HONG XIONG, AIBIN LIANG
    Oncology Reports 2013 29 5
  • Imaging of treatment response during systemic therapy for hepatocellular carcinoma
    William R. Masch, Rony Kampalath, Neehar Parikh, Kimberly A. Shampain, Anum Aslam, Victoria Chernyak
    Abdominal Radiology 2021 46 8
  • A network meta-analysis: the overall and progression-free survival of glioma patients treated by different chemotherapeutic interventions combined with radiation therapy (RT)
    Ling Qi, Lijuan Ding, Shuran Wang, Yue Zhong, Donghai Zhao, Ling Gao, Weiyao Wang, Peng Lv, Ye Xu, Shudong Wang
    Oncotarget 2016 7 42
  • Biochemical Roles of Eukaryotic Cell Surface Macromolecules
    S. Samaddar, B. Ranasinghe, S. J. Tantry, P. R. Debata, P. Banerjee
    2015 842
  • Kombinierte funktionelle und morphologische Bildgebung bei Sarkomen
    N. Schramm, M. Schlemmer, C. Rist, R. Issels, M.F. Reiser, F. Berger
    Der Radiologe 2010 50 4
  • Intraarterial Bevacizumab Administration Through the Middle Meningeal Artery for Chronic Subdural Hematoma
    Jane Khalife, Daniel A. Tonetti, Hamza Shaikh, Tudor Jovin, Pratit Patel, Ajith Thomas
    Stroke: Vascular and Interventional Neurology 2023 3 4
  • Misleading early blood volume changes obtained using ferumoxytol-based magnetic resonance imaging perfusion in high grade glial neoplasms treated with bevacizumab
    Joao Prola Netto, Daniel Schwartz, Csanad Varallyay, Rongwei Fu, Bronwyn Hamilton, Edward A. Neuwelt
    Fluids and Barriers of the CNS 2016 13 1
  • The ubiquitin-like protein FAT10 in hepatocellular carcinoma cells limits the efficacy of anti-VEGF therapy
    Yumin Qiu, Ben Che, Wenming Zhang, A.V. Zhang, Jin Ge, Dongnian Du, Jiajuan Li, Xiaogang Peng, Jianghua Shao
    Journal of Advanced Research 2024 59
  • Angiosuppressive properties of marine-derived compounds—a mini review
    Patrick Y.K. Yue, H.M. Leung, Adela J. Li, Tracy N.C. Chan, T.S. Lum, Y. L. Chung, Y.H. Sung, M.H. Wong, Kelvin S.Y. Leung, Eddy Y. Zeng
    Environmental Science and Pollution Research 2017 24 10
  • Combined Therapy With Avastin, a PAF Receptor Antagonist and a Lipid Mediator Inhibited Glioblastoma Tumor Growth
    Valerie A. Cruz Flores, Hemant Menghani, Pranab K. Mukherjee, Luis Marrero, Andre Obenaus, Quan Dang, Larissa Khoutorova, Madigan M. Reid, Ludmila Belayev, Nicolas G. Bazan
    Frontiers in Pharmacology 2021 12
  • Corneal thinning following bevacizumab intrastromal injection for the treatment of idiopathic lipid keratopathy
    Kristie J. Sun, Albert S. Jun, Kelley Bohm, Daniel Daroszewski, Samir Jabbour
    American Journal of Ophthalmology Case Reports 2022 27
  • Immunology for Engineers
    Sagar, Malemnganba Takhellambam, Aditi Rattan, Vijay Kumar Prajapati
    2024 140
  • Retrospective Study of the Efficacy and Safety of Chemoembolization with Drug-Eluting Microspheres Combined with Intra-Arterial Infusion of Bevacizumab for Unresectable Hepatocellular Carcinoma
    Shota Ueda, Shinichi Hori, Atsushi Hori, Kazuhiro Makitani, Ke Wan, Tetsuo Sonomura
    Journal of Hepatocellular Carcinoma 2022 Volume 9
  • Short-term study on in-use stability of opened bevacizumab biosimilar PF-06439535 vials
    Mona Abdel-Tawab, Markus Waßmuth, Florian Gegenfurtner, Andrea Hawe, Jan H Schefe, Anke M Strunz, Joachim Wübert
    European Journal of Hospital Pharmacy 2024 31 2
  • A Review of the Non-clinical and Clinical Requirements for the performance of a comparability exercise for Bevacizumab biosimilars
    Ammar Almaaytah
    Research Journal of Pharmacy and Technology 2023
  • Assessment of extended urine protein monitoring frequency in patients receiving bevacizumab
    Molly Schiffer, Lejla Zukovic, Sophia Hall, Man Yee Merl
    Journal of Oncology Pharmacy Practice 2021 27 4
  • Heparin potentiates Avastin-mediated inhibition of VEGF binding to fibronectin and rescues Avastin activity at acidic pH
    Divyabharathy Tsiros, Casey E. Sheehy, Surenna Pecchia, Matthew A. Nugent
    Journal of Biological Chemistry 2019 294 46
  • Intra‐arterial Selective Bevacizumab Administration in the Middle Meningeal Artery for Chronic Subdural Hematoma: An Early Experience in 12 Hemispheres
    Jane Khalife, Manisha Koneru, Daniel A. Tonetti, Hamza A. Shaikh, Tudor G. Jovin, Pratit D. Patel, Ajith J. Thomas
    Stroke: Vascular and Interventional Neurology 2024 4 5
  • VEGF inhibitors in glaucoma surgery
    Vardan R Mamikonyan, Sergej Y Petrov, Daria M Safonova
    Ophthalmology Reports 2016 9 1
  • A randomized, double-blind, parallel-group, single‑dose, pharmacokinetic bioequivalence study of INTP24 and bevacizumab in healthy adult men
    Inderjeet Singh, Ronak Patel, Akash Patel, Vinu Jose
    Cancer Chemotherapy and Pharmacology 2020 86 2
  • Colon Cancer Diagnosis and Therapy Vol. 3
    Vikas Chandra, Ashutosh Tiwari, Rajat Pratap Singh, Kartiki V. Desai
    2022
  • Heparin–Avastin Complexes Show Enhanced VEGF Binding and Inhibition of VEGF-Mediated Cell Migration
    Divyabharathy Tsiros, Casey E. Sheehy, Matthew A. Nugent
    International Journal of Translational Medicine 2021 1 2
  • Integrating Vascular Phenotypic and Proteomic Analysis in an Open Microfluidic Platform
    Sangmin Jung, Sunghun Cheong, Yoonho Lee, Jungseub Lee, Jihye Lee, Min-Seok Kwon, Young Sun Oh, Taewan Kim, Sungjae Ha, Sung Jae Kim, Dong Hyun Jo, Jihoon Ko, Noo Li Jeon
    ACS Nano 2024 18 36
  • Navigating therapeutic prospects by modulating autophagy in colorectal cancer
    Deepa Rajendran, Chern Ein Oon
    Life Sciences 2024 358
  • Quantile-specific heritability of serum growth factor concentrations
    Paul T. Williams
    Growth Factors 2021 39 1-6
  • Thyroid Cancer
    David A. Liebner, Sigurdis Haraldsdottir, Manisha H. Shah
    2016
  • VEGF as a Key Actor in Recurrent Respiratory Papillomatosis: A Narrative Review
    Sandra Gazzini, Raffaele Cerullo, Davide Soloperto
    Current Issues in Molecular Biology 2024 46 7
  • Anti-CHI3L1 antibody suppresses colon cancer growth through downregulation of VEGFA and NAMPT expression
    Ji Won Seo, Deok Rim Heo, Ji Eun Yu, A-Young Nam, Na Yeong Lee, Ja Keun Koo, Sang Bae Han, Jung-Hyun Shim, Jin Tae Hong
    Archives of Pharmacal Research 2025
  • Comprehensive Toxicology
    T.V. Dupre, C.N. Sharp, L.J. Siskind
    2018
  • Development of Analytical Method for the Quantitation of Monoclonal Antibodies Solutions via Raman Spectroscopy: The Case of Bevacizumab
    Michail Lykouras, Panagiota Papaspyridakou, Olga E. Makri, Constantine D. Georgakopoulos, Malvina G. Orkoula
    Pharmaceuticals 2024 17 4
  • Drug Selectivity
    Christian Noe, Volker Baumann
    2017
  • Efficacy and safety of TACE combined with tyrosine kinase inhibitors and camrelizumab for unresectable hepatocellular carcinoma: A systematic review and meta‑analysis
    Jiahui Yu, Duan Yan, Song Wei, Linfeng Yang, Pengsheng Yi
    Oncology Letters 2024 28 2
  • Efficacy and safety of neoadjuvant bevacizumab plus chemotherapy in locally advanced gastric cancer patients: a retrospective, comparative study
    Bin Yin, Wei Luo
    World Journal of Surgical Oncology 2025 23 1
  • Efficacy of bevacizumab in hereditary hemorrhagic telangiectasia: a systematic review and network meta-analysis
    Amira Mohamed Taha, Areeba Fareed, Mandy Elewa, Mohammed Tarek Hasan, Toka Elboraay, Khaled Abouelmagd, Marwa Muhammed Abdeljawad
    European Archives of Oto-Rhino-Laryngology 2025
  • Neuroimaging Pharmacopoeia
    Daniel Thomas Ginat, William A. Mehan
    2015
  • Neuroimaging Pharmacopoeia
    Daniel Thomas Ginat, William A. Mehan
    2022
  • Polymeric nanoparticles for the treatment of solid tumors
    Ashish Garg
    2022 71
  • Reference Module in Biomedical Sciences
    Theresa Weis, Andrew Orwick, Tess V Dupre, Cierra N Sharp, Leah J Siskind
    2024
  • Safety of an Intravitreal Bevacizumab Biosimilar (MVASI)
    Hanru Wang, Bobak Bahrami, Sonia Huang, Marzieh Tahmasebi Sarvestani, Sudha Cugati, Stewart Lake, Weng Onn Chan, Devaraj Supramaniam, Matthew Little
    Clinical & Experimental Ophthalmology 2025
  • Surgical Emergencies in the Cancer Patient
    Theresa W. Chan, Niloofar Latifi, Anna Weiss, Sarah L. Blair
    2017
PreviousNext
Back to top

In this issue

American Journal of Neuroradiology: 31 (2)
American Journal of Neuroradiology
Vol. 31, Issue 2
1 Feb 2010
  • Table of Contents
  • Index by author
Advertisement
Print
Download PDF
Email Article

Thank you for your interest in spreading the word on American Journal of Neuroradiology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Bevacizumab (Avastin)
(Your Name) has sent you a message from American Journal of Neuroradiology
(Your Name) thought you would like to see the American Journal of Neuroradiology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Cite this article
S.K. Mukherji
Bevacizumab (Avastin)
American Journal of Neuroradiology Feb 2010, 31 (2) 235-236; DOI: 10.3174/ajnr.A1987

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
0 Responses
Respond to this article
Share
Bookmark this article
Bevacizumab (Avastin)
S.K. Mukherji
American Journal of Neuroradiology Feb 2010, 31 (2) 235-236; DOI: 10.3174/ajnr.A1987
del.icio.us logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Purchase

Jump to section

  • Article
    • Abstract
    • Abbreviations
    • Proposed Mechanism of Action
    • Clinical Indications
    • Administration and Effects
    • Economic Issues
    • Clinical Issues
    • References
  • Figures & Data
  • Info & Metrics
  • Responses
  • References
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Short-term study on in-use stability of opened bevacizumab biosimilar PF-06439535 vials
  • Heparin potentiates Avastin-mediated inhibition of VEGF binding to fibronectin and rescues Avastin activity at acidic pH
  • Dynamic Susceptibility Contrast-Enhanced MR Perfusion Imaging in Assessing Recurrent Glioblastoma Response to Superselective Intra-Arterial Bevacizumab Therapy
  • An exploration of counterfeit medicine surveillance strategies guided by geospatial analysis: lessons learned from counterfeit Avastin detection in the US drug supply chain
  • Posterior reversible encephalopathy syndrome after bevacizumab therapy in a normotensive patient
  • Metabolic Response of Glioblastoma to Superselective Intra-Arterial Cerebral Infusion of Bevacizumab: A Proton MR Spectroscopic Imaging Study
  • Characteristics of Oral Mucosal Events Related to Bevacizumab Treatment
  • Crossref (87)
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • Glioblastoma and chemoresistance to alkylating agents: Involvement of apoptosis, autophagy, and unfolded protein response
    Sabine Hombach-Klonisch, Maryam Mehrpour, Shahla Shojaei, Craig Harlos, Marshall Pitz, Ahmed Hamai, Krzysztof Siemianowicz, Wirginia Likus, Emilia Wiechec, Brian D. Toyota, Reyhane Hoshyar, Amir Seyfoori, Zahra Sepehri, Sudharsana R. Ande, Forough Khadem, Mohsen Akbari, Adrienne M. Gorman, Afshin Samali, Thomas Klonisch, Saeid Ghavami
    Pharmacology & Therapeutics 2018 184
  • Combination therapy with immune checkpoint inhibitors (ICIs); a new frontier
    Somayeh Vafaei, Angelina O. Zekiy, Ramadhan Ado Khanamir, Burhan Abdullah Zaman, Arman Ghayourvahdat, Hannaneh Azimizonuzi, Majid Zamani
    Cancer Cell International 2022 22 1
  • Tumor Volume Estimation and Quasi-Continuous Administration for Most Effective Bevacizumab Therapy
    Johanna Sápi, Levente Kovács, Dániel András Drexler, Pál Kocsis, Dávid Gajári, Zoltán Sápi, Francesco Bertolini
    PLOS ONE 2015 10 11
  • The bone marrow microenvironment – Home of the leukemic blasts
    Manar S Shafat, Bruno Gnaneswaran, Kristian M Bowles, Stuart A Rushworth
    Blood Reviews 2017 31 5
  • Cancer combination therapies by angiogenesis inhibitors; a comprehensive review
    Mohammad Javed Ansari, Dmitry Bokov, Alexander Markov, Abduladheem Turki Jalil, Mohammed Nader Shalaby, Wanich Suksatan, Supat Chupradit, Hasan S. AL-Ghamdi, Navid Shomali, Amir Zamani, Ali Mohammadi, Mehdi Dadashpour
    Cell Communication and Signaling 2022 20 1
  • Structural Basis for Vascular Endothelial Growth Factor Receptor Activation and Implications for Disease Therapy
    Faheem Shaik, Gary Cuthbert, Shervanthi Homer-Vanniasinkam, Stephen Muench, Sreenivasan Ponnambalam, Michael Harrison
    Biomolecules 2020 10 12
  • A highly hemocompatible erythrocyte membrane-coated ultrasmall selenium nanosystem for simultaneous cancer radiosensitization and precise antiangiogenesis
    Ting Liu, Changzheng Shi, Linqi Duan, Zehang Zhang, Liangping Luo, Shreya Goel, Weibo Cai, Tianfeng Chen
    Journal of Materials Chemistry B 2018 6 29
  • Antibodies in oncology
    Vinochani Pillay, Hui K. Gan, Andrew M. Scott
    New Biotechnology 2011 28 5
  • Theranostic applications of selenium nanomedicines against lung cancer
    Shaowei Liu, Weifeng Wei, Jinlin Wang, Tianfeng Chen
    Journal of Nanobiotechnology 2023 21 1
  • Multifunctional Nanocarriers for Simultaneous Encapsulation of Hydrophobic and Hydrophilic Drugs in Cancer Treatment
    Chia-Wei Su, Chih-Sheng Chiang, Wei-Ming Li, Shang-Hsiu Hu, San-Yuan Chen
    Nanomedicine 2014 9 10

More in this TOC Section

  • Dabigatran (Pradaxa)
  • Clopidogrel (Plavix)
  • Trastuzumab (Herceptin)
Show more Pharmacology Vignette

Similar Articles

Advertisement

Indexed Content

  • Current Issue
  • Accepted Manuscripts
  • Article Preview
  • Past Issues
  • Editorials
  • Editors Choice
  • Fellow Journal Club
  • Letters to the Editor

Cases

  • Case Collection
  • Archive - Case of the Week
  • Archive - Case of the Month
  • Archive - Classic Case

Special Collections

  • Special Collections

Resources

  • News and Updates
  • Turn around Times
  • Submit a Manuscript
  • Author Policies
  • Manuscript Submission Guidelines
  • Evidence-Based Medicine Level Guide
  • Publishing Checklists
  • Graphical Abstract Preparation
  • Imaging Protocol Submission
  • Submit a Case
  • Become a Reviewer/Academy of Reviewers
  • Get Peer Review Credit from Publons

Multimedia

  • AJNR Podcast
  • AJNR SCANtastic
  • Video Articles

About Us

  • About AJNR
  • Editorial Board
  • Not an AJNR Subscriber? Join Now
  • Alerts
  • Feedback
  • Advertise with us
  • Librarian Resources
  • Permissions
  • Terms and Conditions

American Society of Neuroradiology

  • Not an ASNR Member? Join Now

© 2025 by the American Society of Neuroradiology All rights, including for text and data mining, AI training, and similar technologies, are reserved.
Print ISSN: 0195-6108 Online ISSN: 1936-959X

Powered by HighWire